Emergence of long-term surviving patients with the introduction of Cetuximab in recurrent/metastatic disease of squamous cell carcinoma of head and neck

MeSH terms

• Aged
• Antineoplastic Agents / therapeutic use*
• Carcinoma, Squamous Cell / drug therapy*
• Cetuximab / therapeutic use*
• Disease-Free Survival
• Female
• Head and Neck Neoplasms / drug therapy*
• Humans
• Male
• Middle Aged
• Neoplasm Recurrence, Local / drug therapy
• Treatment Outcome